Bridging the Translational Gap
Time: 2:00 pm
day: Conference Day One
Details:
- Highlights of our Direct-to-Donor model which provides comprehensive and relevant health data across a large network, spanning 100+ indications
- Overview of how Sanguine's biospecimen products and services for pre-clinical research, assay and process validation drive stronger results
- Examples of success with our partners in the cell therapy development space
